Company Filing History:
Years Active: 1976-1978
Title: The Innovative Contributions of Hans Reimann
Introduction
Hans Reimann is a notable inventor based in Wayne, NJ, who has made significant contributions to the field of antibacterial agents. With a total of six patents to his name, Reimann's work focuses on developing novel compounds that have the potential to combat bacterial infections effectively.
Latest Patents
Among his latest patents is the invention related to Aminoeverninomicin and its derivatives. This patent describes how Everninomicin B, C, or D can be converted into amino derivatives through reductive means. These amino derivatives can further be transformed into novel N-acyl, N-alkyl, or N,N-dialkyl derivatives. Additionally, the patent outlines a method for converting Everninomicins B, C, or D into N-acyl-N-hydroxylamino derivatives, which are also produced through reductive means. The resulting derivatives, along with their non-toxic pharmaceutically acceptable cationic salts, are recognized as novel antibacterial agents.
Another significant patent involves the development of monoesters of rosamicin, also known as Antibiotic 67-694. This patent details a process for preparing these monoesters through the selective solvolysis of diester precursors. The monoesters are identified as broad-spectrum antibacterial agents, particularly effective against gram-positive bacteria.
Career Highlights
Hans Reimann is currently associated with Schering Corporation, where he continues to innovate in the field of pharmaceuticals. His work has contributed to advancements in antibacterial treatments, showcasing his commitment to improving public health through scientific research.
Collaborations
Throughout his career, Reimann has collaborated with esteemed colleagues such as Jan Ilavsky and Aris P Bayan. These collaborations have likely enriched his research and contributed to the successful development of his patented inventions.
Conclusion
Hans Reimann's innovative work in the field of antibacterial agents highlights his significant contributions to medical science. His patents reflect a dedication to developing effective treatments that address pressing health challenges.